RMEA.F Resmed Inc DRC

Healthcare Health Care Equipment & Supplies Frankfurt Exchange
21.20 EUR
Close of Nov 13, 2026
15.21 22.93
Market cap
EUR 29.8B
P/E
22.3x
P/B
5.39x
ROE
28.1%
Dividend yield
1.16%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Sep 2026.

Is RMEA.F undervalued?

Graham number
Price21.20
Graham value9.17
Premium131.2%

RMEA.F trades 131.2% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Resmed Inc DRC fundamental analysis

No fundamental analysis for Resmed Inc DRC yet.

Resmed Inc DRC stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Resmed Inc DRC

ResMed Inc. engages in the digital health and cloud-connected medical devices business in the United States and internationally. It operates in two segments, Sleep and Breathing Health, and Residential Care Software. The company offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, hospitals, and at home, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; NightOwl…

Full company profile